# Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C

> **NCT00629824** · PHASE4 · COMPLETED · sponsor: **Kaohsiung Medical University Chung-Ho Memorial Hospital** · enrollment: 250 (estimated)

## Conditions studied

- Chronic Hepatitis C

## Interventions

- **DRUG:** pegylated interferon alpha and plus ribavirin
- **DRUG:** pegylated interferon alpha and plus ribavirin
- **DRUG:** pegylated interferon alpha and plus ribavirin

## Key facts

- **NCT ID:** NCT00629824
- **Lead sponsor:** Kaohsiung Medical University Chung-Ho Memorial Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-02
- **Primary completion:** 2009-04
- **Final completion:** 2009-04
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2010-09-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00629824

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00629824, "Pegylated Interferon Plus Ribavirin in Treating Older Patients With Chronic Hepatitis C". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00629824. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
